Clinical Trial Update: A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy of RWJ-333369 for prevention of migraine headaches has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• RWJ 333369 (RWJ-333369)

Snippet

Sponsor: SK Life Science, Inc. | Conditions: Migraine Headaches | Phase 2 | Status: COMPLETED